GCG and diabetes mellitus: Glucagon-like peptide-1 receptor agonists (GLP-1-RAs), US Food and Drug Administration-approved for diabetes and weight loss, have recently shown promise in small case studies reporting improved glycemic control and decreased HS severity over short durations.3, 4, 5